23RD JUNE 2025
From 23 June 2025, the prescribing of Mounjaro (Tirzepatide) in General Practice will follow updated NHS criteria.
Who is Eligible?
As part of the phased roll out, Mounjaro (TIrzepatide) will only initially be offered to Adult patients who meet the following criteria:
- Must have a BMI equal to or over 40
- Must have 4 confirmed diagnoses of the following 5 health related problems :
-
- Type 2 Diabetes
- Hypertension
- Dyslipidaemia
- Cardiovascular Disease
- Obstructive Sleep Apnoea
Who should NOT take Mounjaro?
- Anyone under the age of 18
- Are pregnant or breast feeding
- Personal or family history of Medullary Thyroid Carcinoma (MTC)
- Multiple Endocrine Neoplasia Syndrome Type 2 (MEN2)
- Hypersensitivity to Tirzepatide or any of its components
What You Need to Do if you believe you meet the criteria :
- We must have a BMI noted on your records in the last 3 months, if we do not hold this information then please book an appointment to have your height, weight and BMI measured with the Health Care Assistant. If your BMI is 40 or over then you will be advised of next steps.
- Do not stop any current medication without advice
What if my BMI is below 40?
- If your BMI is below 40 you are not eligible for Mounjaro on the NHS at the current time, however we can offer you referral and advice with regards to weight management